In Vivo Screening Data Summary

NCI In Vivo Screening Data

L1210 Leukemia (intracerebral) in CD2F1 (CDF1) mice

NSC 3063
CAS 148-51-6
SK 591; NSC 3063; 4-Desoxyadermin

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q01DX005 (ip) median survival time Klucel (hydroxypropylcellulose) (HPC) 128.0 mg/kg/injection 106.0 Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time Klucel (hydroxypropylcellulose) (HPC) 128.0 mg/kg/injection 105.0 Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time Klucel (hydroxypropylcellulose) (HPC) 256.0 mg/kg/injection 111.0 Antitumor endpoint evaluated on day 30; 09/10 animals surviving on day 5
Q01DX005 (ip) median survival time Klucel (hydroxypropylcellulose) (HPC) 256.0 mg/kg/injection 114.0 Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time Klucel (hydroxypropylcellulose) (HPC) 512.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 30; 00/10 animals surviving on day 5
Q01DX005 (ip) median survival time Klucel (hydroxypropylcellulose) (HPC) 512.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 30; 00/10 animals surviving on day 5
Q01DX005 (ip) median survival time Klucel (hydroxypropylcellulose) (HPC) 1024.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 30; 00/10 animals surviving on day 5
Q01DX005 (ip) median survival time Klucel (hydroxypropylcellulose) (HPC) 1024.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 30; 00/10 animals surviving on day 5